ACHIEVE LIFE SCIENCES, INC. (ACHV) [Rocket]

Overview

ACHIEVE LIFE SCIENCES, INC. (ACHV)

Add to portfolio

1m \| 3m \| 6m \| 1y \| 2y \| 5y \| 10y

Recent News + Filings (All items)

Date Filed	Type	Description
08/14/2023	10-Q	Quarterly Report for the period ended June 30, 2023
08/14/2023	8-K	Quarterly results
06/09/2023	4	HIMES VAUGHN B (Director) has filed a Form 4 on ACHIEVE LIFE SCIENCES, INC.
06/09/2023	4	Martell Bridget A (Director) has filed a Form 4 on ACHIEVE LIFE SCIENCES, INC.
06/09/2023	4	Sellig Thomas (Director) has filed a Form 4 on ACHIEVE LIFE SCIENCES, INC.
06/09/2023	4	Duty Stuart (Director) has filed a Form 4 on ACHIEVE LIFE SCIENCES, INC.
06/09/2023	4	KING THOMAS BRAXTON (Director) has filed a Form 4 on ACHIEVE LIFE SCIENCES, INC.

Revenue Mix by Segment

Financial Summary (All financials)

In millions, except per share items	Dec-31-22	Dec-31-21	Dec-31-20	Dec-31-19	Dec-31-18	Dec-31-17	Sep-30-17	Dec-31-16
Revenues	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0
Revenue growth							360.2%
Cost of goods sold	0.0	0.0	0.0	0.0	0.0	8.6	2.9	0.0
Gross profit	0.0	0.0	0.0	0.0	0.0	-8.6	-1.9	0.0
Gross margin							-200.6%
Selling, general and administrative
Research and development	30.1	24.0	6.9	9.7	5.9	3.1		0.3
General and administrative	10.7	9.1	7.9	6.9	6.9	3.5	1.9	1.4
EBITA	-40.6	-32.9	-14.8	-16.3	-12.6	-21.9	-2.9	-1.5
EBITA margin							-300.6%
Amortization of intangibles	0.2	0.2		0.2	0.2	0.2		0.2
EBIT	-40.8	-33.1	-14.8	-16.5	-12.8	-22.1	-2.9	-1.7
EBIT margin							-300.6%
Pre-tax income	-42.4	-33.2	-14.7	-16.4	-12.7	-13.6	-9.9	-1.7
Income taxes	0.0	0.0	0.0	0.0	0.0	-3.1	-3.1	-0.5
Tax rate	0.0%	0.0%	0.0%	0.0%	0.0%	22.4%	30.8%	29.0%
Net income	-42.4	-33.2	-14.7	-16.4	-12.7	-10.6	-6.8	-1.2
Net margin							-721.8%

Diluted EPS	($4.00)	($4.08)	($5.42)	($39.76)	($72.29)	($22.07)	($2.81)	($581.25)
Shares outstanding (diluted)	10.6	8.1	2.7	0.4	0.2	0.5	2.4	0.0

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.